Abstract:1368 Therapeutic selectivity is important for anticancer drug development. Understanding the biological differences between normal and cancer cells is essential in designing strategies to preferentially kill cancer cells. Compared to normal cells, most cancer cells exhibit high metabolic activity, generate increased levels of reactive oxygen species (ROS), and are under oxidative stress. Elevated ROS renders the cancer cells more vulnerable to further ROS stress by exogenous ROS-generating agents. Here, we report that immortalization of ovarian epithelial cells with SV40 and hTERT followed by transformation with H-RasV12 oncogene rendered the cells tumorigenic, and exhibited significantly higher ROS generation compared to the non-tumorigenic parental cells. The malignant cells were highly vulnerable to further oxidative stress by β-phenylethyl isothiocyanates (PEITC), a dietary metabolic product of cruciferous vegetables. Treatment with 10 μM PEITC for 5 h preferentially induced ROS generation in (15-19 fold increase) and induced massive cell death (60-80%) within a relatively short period (5-24 h). In contrast, the parental non-tumorigenic cells without ras-transformation exhibited low basal ROS generation and better tolerated PEITC-induced ROS stress, as evidenced by only a modest ROS increase and less cell death (10-20%, 10 μM, 5-24 h). The in vitro therapeutic selectivity of PEITC against ovarian cancer cells was superior to cisplatin. Further studies revealed that PEITC caused a more severe depletion of glutathione in the malignant cells (93%, 5 μM, 3h) compared to the non-tumorigenic cells (52%), which appeared to be a biochemical mechanism for preferential increase of ROS in the malignant cells. Mechanistic studies demonstrated that PEITC induced cell death by causing a striking ROS-mediated oxidative damage to the mitochondrial membranes, and disrupting the redox-sensitive survival pathways such as NF-KB and Ras in the cancer cells. The action of PEITC was reversed by antioxidant N-acetylcysteine and ROS scavenger enzyme catalase. The promising therapeutic activity of PEITC was further demonstrated in animal models bearing the ras-transformed ovarian cancer cells, with an 84% increase in median animal survival time (25 vs 48 days, p

Isothiocyanates suppress the metastasis of non-small cell lung cancer cells through a ROS-mediated mechanism

Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers

Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m6A modification

Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells

PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT

The Role of Cruciferous Vegetables and Isothiocyanates for Lung Cancer Prevention: Current Status, Challenges, and Future Research Directions

Isoquercitrin Inhibits Lung Cancer Cell Growth Through Triggering Pyroptosis and Ferroptosis

A Presurgical-Window Intervention Trial of Isothiocyanate-Rich Broccoli Sprout Extract in Patients with Breast Cancer

A principal mechanism for the cancer chemopreventive activity of phenethyl isothiocyanate is modulation of carcinogen metabolism

Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Anti-NF-kappaB and Anti-Inflammatory Activities of Synthetic Isothiocyanates: Effect of Chemical Structures and Cellular Signaling.

Dietary isothiocyanates inhibit cancer progression by modulation of epigenome

Irreversible Inhibition of Glutathione S-Transferase by Phenethyl Isothiocyanate (PEITC), a Dietary Cancer Chemopreventive Phytochemical.

Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells

Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Selective Killing of Oncogenic Transformed Cells Through ROS-mediated Mechanism by Β-Phenylethyl Isothiocyanates

The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents

Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo

Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells

Allyl isothiocyanate regulates oxidative stress, inflammation, cell proliferation, cell cycle arrest, apoptosis, angiogenesis, invasion and metastasis via interaction with multiple cell signaling pathways